
Institutions Enroll First Alzheimer’s Patients in CARE PMR Study
Hyperfine, Inc. (Nasdaq: HYPR), known for its groundbreaking health technology, has initiated the CARE PMR observational study, enrolling the first patients. The study aims to evaluate the clinical utility and workflow benefits of its FDA-cleared portable magnetic resonance (MR) brain…












